Psychiatric Disorders Clinical Trial
Official title:
Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus
The purpose of this study is to determine the role of inflammation in the high prevalence of psychiatric disorders in skin-restricted lupus (SRL) patients. SRL is an inflammatory disease. Inflammation can lead to a decrease in the synthesis of neurotransmitters via the activation of the IDO enzyme and to induce the synthesis of neurotoxic molecules (kynurenin pathway). This leads to the development of psychiatric disorders. Investigator therefore want to compare inflammation and neurotransmitter synthesis in SRL patients according to the presence or absence of psychiatric disorders. Investigator expect a decrease in neurotransmitter synthesis and activation of the kynurenin pathway in patients with a psychiatric disorder.
The purpose of this study is to determine the role of inflammation in the high prevalence of psychiatric disorders in skin-restricted lupus (SRL) patients. SRL is an inflammatory disease. Inflammation can lead to a decrease in the synthesis of neurotransmitters via the activation of the IDO enzyme and to induce the synthesis of neurotoxic molecules (kynurenin pathway). This leads to the development of psychiatric disorders. Investigator therefore want to compare inflammation and neurotransmitter synthesis in SRL patients according to the presence or absence of psychiatric disorders. Investigator expect a decrease in neurotransmitter synthesis and activation of the kynurenin pathway in patients with a psychiatric disorder. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00166764 -
A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders
|
N/A | |
Recruiting |
NCT06062953 -
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
|
Phase 2/Phase 3 | |
Recruiting |
NCT05548946 -
A Dimensional Model for Personality Disorders in Later Life
|
N/A | |
Completed |
NCT03313154 -
Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related
|
||
Completed |
NCT00783783 -
CYP2D6 Pharmacogenetics in Risperidone-Treated Children
|
N/A | |
Completed |
NCT01989728 -
Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence
|
N/A | |
Recruiting |
NCT01066299 -
Influence of Oxytocin on the Startle Reflex and on Its Modulation
|
N/A | |
Completed |
NCT02987426 -
Can Brief-mindfulness Interventions Improve Psychiatric Symptoms?
|
Phase 2/Phase 3 | |
Recruiting |
NCT05784818 -
Up To Me: Erasing the Stigma of Mental Illness on College Campuses
|
N/A | |
Completed |
NCT01786733 -
Behavioral Activation - From Inpatient to Outpatient Services
|
N/A | |
Withdrawn |
NCT03907124 -
Clinical Utility of Pharmacogenomics of Psychotropic Medications
|
Phase 4 | |
Withdrawn |
NCT03809897 -
Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders
|
Phase 4 | |
Not yet recruiting |
NCT02857322 -
Effectiveness Accompaniment Perioperative Patients With Psychiatric Illness on the Lives Perioperative
|
N/A | |
Terminated |
NCT02665988 -
Adjunctive Transcranial Direct Current Stimulation
|
N/A | |
Completed |
NCT01289080 -
Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
|
Phase 1 | |
Completed |
NCT01823250 -
Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial
|
Phase 2 | |
Active, not recruiting |
NCT00982943 -
The Epidemiological Study on Psychiatric Disorders and Psychotropic Drugs
|
N/A | |
Completed |
NCT00184340 -
Secured Internet-mediated Psychotherapy With Psychiatry Patients
|
N/A | |
Completed |
NCT00184327 -
Changes Following Inpatient Child-oriented Family Treatment
|
Phase 1 | |
Recruiting |
NCT04381845 -
Immunity and Infections in the Psychiatric Population
|
N/A |